Alterity Therapeutics Files 6-K, Incorporates by Reference
Ticker: PRNAF · Form: 6-K · Filed: Jul 3, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Jul 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: registration-statement, sec-filing, compliance
Related Tickers: ATH
TL;DR
Alterity Therapeutics (ATH) filed a 6-K on 7/3/25, mainly to update registration statements. Nothing new on pipeline.
AI Summary
Alterity Therapeutics Limited filed a Form 6-K on July 3, 2025, to incorporate by reference into several of its existing Registration Statements on Form S-8 and Form F-3. The filing includes Exhibit 99.1, a notification regarding unquoted securities for ATH.
Why It Matters
This filing is procedural, indicating the company is updating or maintaining its registration statements for securities, which is important for ongoing compliance and potential future offerings.
Risk Assessment
Risk Level: low — The filing is a routine administrative update and does not contain new material financial or operational information that would significantly alter the company's risk profile.
Key Players & Entities
- Alterity Therapeutics Limited (company) — Registrant
- ATH (company) — Ticker symbol for Alterity Therapeutics
- July 3, 2025 (date) — Filing date
- Form S-8 (document) — Registration statement type
- Form F-3 (document) — Registration statement type
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is being incorporated by reference into Alterity Therapeutics' existing Registration Statements on Form S-8 and Form F-3.
What specific exhibit is included with this filing?
Exhibit 99.1, a notification regarding unquoted securities for ATH, is submitted with this Form 6-K.
When was this Form 6-K filed?
This Form 6-K was filed on July 3, 2025.
Does Alterity Therapeutics file annual reports under Form 20-F or 40-F?
Alterity Therapeutics indicates it files annual reports under Form 20-F.
What is the principal executive office address for Alterity Therapeutics?
The principal executive office is located at Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 3, 2025 regarding ALTERITY THERAPEUTICS LTD (PRNAF).